Conecte-se

Bibliografias temáticas / Drugs Metabolism / Artigos de revistas

Siga este link para ver outros tipos de publicações sobre o tema: Drugs Metabolism.

Artigos de revistas sobre o tema "Drugs Metabolism"

Autor: Grafiati

Publicado: 4 de junho de 2021

Última modificação: 26 de julho de 2024

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Drugs Metabolism".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

Lambie, David G., and Ralph H. Johnson. "Drugs and Folate Metabolism." Drugs 30, no. 2 (August 1985): 145–55. http://dx.doi.org/10.2165/00003495-198530020-00003.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Desouza, Cyrus, Mary Keebler, Dennis B. McNamara, and Vivian Fonseca. "Drugs Affecting Homocysteine Metabolism." Drugs 62, no. 4 (2002): 605–16. http://dx.doi.org/10.2165/00003495-200262040-00005.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Jann, Michael W., Y. W. Francis Lam, Eric C. Gray, and Wen-Ho Chang. "REVERSIBLE METABOLISM OF DRUGS." Drug Metabolism and Drug Interactions 11, no. 1 (January 1994): 1–24. http://dx.doi.org/10.1515/dmdi.1994.11.1.1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Reiher, Jean. "Metabolism of Antiepileptic Drugs." Journal of Clinical Neurophysiology 2, no. 3 (July 1985): 309. http://dx.doi.org/10.1097/00004691-198507000-00007.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Franceschini, Guido, and Rodolfo Paoletti. "Drugs controlling triglyceride metabolism." Medicinal Research Reviews 13, no. 2 (March 1993): 125–38. http://dx.doi.org/10.1002/med.2610130202.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Ghiselli, Giancarlo, and Marco Maccarana. "Drugs affecting glycosaminoglycan metabolism." Drug Discovery Today 21, no. 7 (July 2016): 1162–69. http://dx.doi.org/10.1016/j.drudis.2016.05.010.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Kostner, G. M. "Drugs affecting lipid metabolism." Chemistry and Physics of Lipids 51, no. 1 (July 1989): 73–74. http://dx.doi.org/10.1016/0009-3084(89)90068-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Durrington, P. "Drugs Affecting Lipid Metabolism." International Journal of Cardiology 45, no. 2 (June 1994): 153–54. http://dx.doi.org/10.1016/0167-5273(94)90276-3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Sitar, Daniel S. "Metabolism of Thioamide Antithyroid Drugs." Drug Metabolism Reviews 22, no. 5 (January 1990): 477–502. http://dx.doi.org/10.3109/03602539008991448.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Kelly, Patrick, and Barry Kahan. "Review: Metabolism of Immunosuppressant Drugs." Current Drug Metabolism 3, no. 3 (June 1, 2002): 275–87. http://dx.doi.org/10.2174/1389200023337630.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Andrade, Chittaranjan. "Drugs That Escape Hepatic Metabolism." Journal of Clinical Psychiatry 73, no. 07 (July 15, 2012): e889-e890. http://dx.doi.org/10.4088/jcp.12f07726.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

Le Couteur, D. G., A. J. McLachlan, and R. de Cabo. "Aging, Drugs, and Drug Metabolism." Journals of Gerontology Series A: Biological Sciences and Medical Sciences 67A, no. 2 (July 18, 2011): 137–39. http://dx.doi.org/10.1093/gerona/glr084.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Davis, T. M. E. "Antimalarial drugs and glucose metabolism." British Journal of Clinical Pharmacology 44, no. 1 (July 1997): 1–7. http://dx.doi.org/10.1046/j.1365-2125.1997.00597.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

Bogliun, G., E. Beghi, V. Crespi, L. Delodovici, and P. D'Amico. "Anticonvulsant drugs and bone metabolism." Acta Neurologica Scandinavica 74, no. 4 (January 29, 2009): 284–88. http://dx.doi.org/10.1111/j.1600-0404.1986.tb03515.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Rizos, Christos V. "Antihypertensive drugs and glucose metabolism." World Journal of Cardiology 6, no. 7 (2014): 517. http://dx.doi.org/10.4330/wjc.v6.i7.517.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Eugene Ramsay, R., and B. J. Wilder. "Metabolism of tricyclic anticonvulsant drugs." Epilepsy & Behavior 3, no. 3 (June 2002): S2—S6. http://dx.doi.org/10.1016/s1525-5050(02)00013-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Sarti, Federica, Jan Barthelmes, Javed Iqbal, Fabian Hintzen, and Andreas Bernkop-Schnürch. "Intestinal enzymatic metabolism of drugs." Journal of Pharmacy and Pharmacology 63, no. 3 (February 8, 2011): 392–99. http://dx.doi.org/10.1111/j.2042-7158.2010.01224.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Rowe, Thomas C., Volkmar Weissig, and Jeffrey W. Lawrence. "Mitochondrial DNA metabolism targeting drugs." Advanced Drug Delivery Reviews 49, no. 1-2 (July 2001): 175–87. http://dx.doi.org/10.1016/s0169-409x(01)00133-8.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Djakovic-Svajcer, Kornelija. "Food and drugs." Medical review 55, no. 1-2 (2002): 5–12. http://dx.doi.org/10.2298/mpns0202005d.

Texto completo da fonte

Resumo:

Food can exert a significant influence on the effects of certain drugs. The interactions between food and drugs can be pharmacokinetic and pharmacodynamic. Pharmacokinetic interactions most often take place on absorption and drug metabolism levels. Absorption can be either accelerated or delayed, increased or decreased, while drug metabolism can be either stimulated or inhibited. The factors which influence food-drug interactions are as follows: composition and physic-chemical properties of drugs, the interval between a meal and drug intake and food composition. Food consistency is of lesser influence on drug bioavailability than food composition (proteins, fats, carbohydrates, cereals). Important interactions can occur during application of drugs with low therapeutic index, whereby the plasma level significantly varies due to changes in resorption or metabolism (e.g. digoxin, theophyllin, cyclosporin) and drugs such as antibiotics, whose proper therapeutic effect requires precise plasma concentrations.

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Melent’ev, A. B., and S. S. Kataev. "Metabolism of designer drugs. Piperazine derivatives." Sudebno-meditsinskaya ekspertiza 58, no. 4 (2015): 49. http://dx.doi.org/10.17116/sudmed201558349-55.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Krishna, Devarakonda R., and Ulrich Klotz. "Extrahepatic Metabolism of Drugs in Humans." Clinical Pharmacokinetics 26, no. 2 (February 1994): 144–60. http://dx.doi.org/10.2165/00003088-199426020-00007.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Ruano, J., F. Fuentes, F. Perez-Jimenez, and J. Lopez-Miranda. "Pharmacogenetics of Drugs Influencing Lipidic Metabolism." Current Genomics 6, no. 2 (March 1, 2005): 115–26. http://dx.doi.org/10.2174/1389202053642311.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

&NA;. "Zidovudine metabolism inhibited by numerous drugs." Reactions Weekly &NA;, no. 416 (August 1992): 2. http://dx.doi.org/10.2165/00128415-199204160-00001.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Staack, Roland, and Hans Maurer. "Metabolism of Designer Drugs of Abuse." Current Drug Metabolism 6, no. 3 (June 1, 2005): 259–74. http://dx.doi.org/10.2174/1389200054021825.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

KOBASHI, Kyoichi, Teruaki AKAO, Masao HATTORI, and Tsuneo NAMBA. "Metabolism of Drugs by Intestinal Bacteria." Bifidobacteria and Microflora 11, no. 1 (1992): 9–23. http://dx.doi.org/10.12938/bifidus1982.11.1_9.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

JANCIN, BRUCE. "Older Antiseizure Drugs Boost Statin Metabolism." Internal Medicine News 38, no. 5 (March 2005): 46. http://dx.doi.org/10.1016/s1553-3212(05)70336-8.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Quiney, Jeremy. "Review of drugs affecting lipid metabolism." Clinica Chimica Acta 179, no. 2 (February 1989): 217. http://dx.doi.org/10.1016/0009-8981(89)90176-9.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

ICHIHARA, Kazuo. "Ischemic myocardial metabolism and antianginal drugs." Folia Pharmacologica Japonica 88, no. 6 (1986): 403–12. http://dx.doi.org/10.1254/fpj.88.403.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

George, Joseph. "Metabolism and interactions of antileprosy drugs." Biochemical Pharmacology 177 (July 2020): 113993. http://dx.doi.org/10.1016/j.bcp.2020.113993.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Theodore, William H. "Antiepileptic Drugs and Cerebral Glucose Metabolism." Epilepsia 29, s2 (August 1988): S48—S55. http://dx.doi.org/10.1111/j.1528-1157.1988.tb05797.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Gescher, Andreas, and Michael D. Threadgill. "The metabolism of triazene antitumor drugs." Pharmacology & Therapeutics 32, no. 2 (January 1987): 191–205. http://dx.doi.org/10.1016/0163-7258(87)90059-3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Kuznetsov, S. G., and S. M. Chigareva. "Metabolism and directed synthesis of drugs." Pharmaceutical Chemistry Journal 23, no. 7 (July 1989): 602–7. http://dx.doi.org/10.1007/bf00764667.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Sulikowski, Tadeusz. "Metabolism of model drugs in the state of experimental cholestasis." Szczecińskie Roczniki Naukowe X, no. 1 (1996): 23–40. http://dx.doi.org/10.3750/stn/srn/t10/z1/02.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

&NA;. "Colony-stimulating factors may alter drugs?? metabolism." Inpharma Weekly &NA;, no. 1059 (October 1996): 20. http://dx.doi.org/10.2165/00128413-199610590-00044.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Melent’ev, A. B., and S. S. Kataev. "Metabolism of designer drugs. The fentanyl derivatives." Sudebno-meditsinskaya ekspertiza 58, no. 5 (2015): 39. http://dx.doi.org/10.17116/sudmed201558539-46.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Natesan, Vijayakumar, and Sung-Jin Kim. "Lipid Metabolism, Disorders and Therapeutic Drugs - Review." Biomolecules & Therapeutics 29, no. 6 (November 1, 2021): 596–604. http://dx.doi.org/10.4062/biomolther.2021.122.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Hagberg, Bengt, and Andreas Killander. "ANTICONVULSIVE DRUGS AND DISTURBED FOLIC ACID METABOLISM." Developmental Medicine & Child Neurology 9, no. 5 (November 12, 2008): 647–48. http://dx.doi.org/10.1111/j.1469-8749.1967.tb02342.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Luca, K. De, R. E. Masotti, and M. W. Partington. "Altered Calcium Metabolism due to Anticonvulsant Drugs." Developmental Medicine & Child Neurology 14, no. 3 (November 12, 2008): 318–21. http://dx.doi.org/10.1111/j.1469-8749.1972.tb02596.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Borusiak, Peter, Thorsten Langer, Marion Heruth, Michael Karenfort, Ulrich Bettendorf, and Andreas CW Jenke. "Antiepileptic Drugs and Bone Metabolism in Children." Journal of Child Neurology 28, no. 2 (May 2012): 176–83. http://dx.doi.org/10.1177/0883073812443005.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Koren, Gideon. "Accelerated Metabolism of Drugs in Late Pregnancy." Therapeutic Drug Monitoring 26, no. 1 (February 2004): 2. http://dx.doi.org/10.1097/00007691-200402000-00002.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Agúndez, José A. G., Cristobalina Mayorga, and Elena García-Martin. "Drug metabolism and hypersensitivity reactions to drugs." Current Opinion in Allergy and Clinical Immunology 15, no. 4 (August 2015): 277–84. http://dx.doi.org/10.1097/aci.0000000000000174.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Moretti, A., A. Gorini, and R. F. Villa. "Affective disorders, antidepressant drugs and brain metabolism." Molecular Psychiatry 8, no. 9 (August 21, 2003): 773–85. http://dx.doi.org/10.1038/sj.mp.4001353.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Packard, C. J. "Effects of drugs on postprandial lipoprotein metabolism." Proceedings of the Nutrition Society 56, no. 2 (July 1997): 745–51. http://dx.doi.org/10.1079/pns19970075.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Hubbard, J. W., K. K. Midha, E. M. Hawes, G. McKAY, S. R. Marder, M. Aravagiri, and E. D. Korchinski. "Metabolism of Phenothiazine and Butyrophenone Antipsychotic Drugs." British Journal of Psychiatry 163, S22 (December 1993): 19–24. http://dx.doi.org/10.1192/s0007125000292556.

Texto completo da fonte

Resumo:

Whereas some metabolites of antipsychotic drugs are psychoactive and contribute to clinical improvement, recent studies have provided evidence that certain metabolites contribute to side-effects which can be disabling enough to negate clinical improvement as regards the psychosis. The route of administration of the drug can determine the amount of metabolite produced in the body and affect how the patient feels in response to the treatment.

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Kharazmi, Arsalan. "Antimalarial drugs and human neutrophil oxidative metabolism." Transactions of the Royal Society of Tropical Medicine and Hygiene 80, no. 1 (January 1986): 94–97. http://dx.doi.org/10.1016/0035-9203(86)90205-1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

Goldin, Barry R. "Intestinal Microflora: Metabolism of Drugs and Carcinogens." Annals of Medicine 22, no. 1 (January 1990): 43–48. http://dx.doi.org/10.3109/07853899009147240.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Verrotti, Alberto, Giangennaro Coppola, Pasquale Parisi, Angelika Mohn, and Francesco Chiarelli. "Bone and calcium metabolism and antiepileptic drugs." Clinical Neurology and Neurosurgery 112, no. 1 (January 2010): 1–10. http://dx.doi.org/10.1016/j.clineuro.2009.10.011.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Slørdal, Lars, and Jarle Aarbakke. "Effect of anticancer drugs on drug metabolism." Pharmacology & Therapeutics 35, no. 1-2 (January 1987): 217–26. http://dx.doi.org/10.1016/0163-7258(87)90107-0.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Rubin, R. L. "Neutrophil-mediated metabolism of autoimmunity inducing drugs." European Journal of Pharmacology 183, no. 1 (July 1990): 79–80. http://dx.doi.org/10.1016/0014-2999(90)91335-9.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

de Groot, Marcel J. "Designing better drugs: predicting cytochrome P450 metabolism." Drug Discovery Today 11, no. 13-14 (July 2006): 601–6. http://dx.doi.org/10.1016/j.drudis.2006.05.001.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!